Kate Taylor • UCLA Profiles

Kate Basia Taylor

Title(s)	Associate Professor-in-Residence, Psychiatry and Biobehavioral Sciences
School	Medicine
ORCID	0000-0001-6199-4350
vCard	Download vCard

Biography

Education and Training

UCLA, Los Angeles, CA	postdoctoral fellowship	07/2012	clinical psychology
Medical University of South Carolina, Charleston. SC	internship	08/2009	clinical psychology
University of Texas at Austin, Austin, TX	Ph.D.	08/2009	clinical psychology
University of Texas at Austin, Austin, TX	M.A.	10/2005	clinical psychology
Emory University, Atlanta, GA	B.A.	05/2002	psychology

Overview

Websites

	UCLA Semel Institute Division of Psychology Profile
	UCLA Cannabis Research Initiative Members
	UCLA STAND ALACRITY Center
	UCLA Anxiety and Depression Research Center Profile
	UCLA Integrated Substance Abuse Profile

ORNG Applications

Clinical Trials

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Integrated behavioral treatments for comorbid anxiety and substance use disorders: A model for understanding integrated treatment approaches and meta-analysis to evaluate their efficacy. Drug Alcohol Depend. 2023 Dec 01; 253:110990. Wolitzky-Taylor K. . PMID: 37866006.

View in: PubMed Mentions: Fields:
Sub Substance-Related Disorders
Translation:Humans
Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trial. Contemp Clin Trials. 2023 Oct; 133:107334. Wolitzky-Taylor K, Mooney LJ, Otto MW, Metts A, Parsons EM, Hanano M, Ram R. PMID: 37730196; PMCID: PMC10960249.

View in: PubMed Mentions: Fields:
Med Medicine (General)The Therapeutics
Translation:Humans
Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept. Behav Res Ther. 2022 03; 150:104032. Wolitzky-Taylor K, Glasner S, Tanner A, Ghahremani DG, London ED. PMID: 35032700.

View in: PubMed Mentions: 4 Fields:
Beh Behavioral Sciences The Therapeutics
Translation:Humans Animals
Development and Initial Pilot Testing of a fully integrated treatment for comorbid social anxiety disorder and alcohol use disorder in a community-based SUD clinic setting. Behav Res Ther. 2022 01; 148:103999. Wolitzky-Taylor K, Sewart A, Karno M, Ries R, Stimson J. PMID: 34813986.

View in: PubMed Mentions: 1 Fields:
Beh Behavioral Sciences The Therapeutics
Translation:Humans
Rumination and worry as putative mediators explaining the association between emotional disorders and alcohol use disorder in a longitudinal study. Addict Behav. 2021 08; 119:106915. Wolitzky-Taylor K, Sewart A, Zinbarg R, Mineka S, Craske MG. PMID: 33770722.

View in: PubMed Mentions: 5 Fields:
Beh Behavioral Sciences Sub Substance-Related Disorders
Translation:Humans
Quality of life in patients with autosomal dominant tubulointerstitial kidney disease . Clin Nephrol. 2019 Dec; 92(6):302-311. Bleyer AJ, Kidd K, Johnson E, Robins V, Martin L, Taylor A, Pinder AJ, Bowline I, Frankova V, Živná M, Taylor KB, Kim N, Baek JJ, Hartmannová H, Hodanová K, Vyletal P, Votruba M, Kmoch S. PMID: 31587753.

View in: PubMed Mentions: 1 Fields:
Nep Nephrology
Translation:Humans
Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users. Behav Res Ther. 2018 08; 107:34-41. Wolitzky-Taylor K, Drazdowski TK, Niles A, Roy-Byrne P, Ries R, Rawson R, Craske MG. PMID: 29852309; PMCID: PMC10980288.

View in: PubMed Mentions: 10 Fields:
Beh Behavioral Sciences The Therapeutics
Translation:Humans
Who needs more than standard care? Treatment moderators in a randomized clinical trial comparing addiction treatment alone to addiction treatment plus anxiety disorder treatment for comorbid anxiety and substance use disorders. Behav Res Ther. 2018 08; 107:1-9. Wolitzky-Taylor K, Niles AN, Ries R, Krull JL, Rawson R, Roy-Byrne P, Craske M. PMID: 29800622.

View in: PubMed Mentions: 7 Fields:
Beh Behavioral Sciences The Therapeutics
Translation:Humans
A Preliminary Exploration of the Barriers to Delivering (and Receiving) Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health Settings. Community Ment Health J. 2018 10; 54(7):899-911. Wolitzky-Taylor K, Fenwick K, Lengnick-Hall R, Grossman J, Bearman SK, Arch J, Miranda J, Chung B. PMID: 29524078; PMCID: PMC6129437.

View in: PubMed Mentions: 8 Fields:
Psy Psychology
Translation:Humans
Stakeholder Perceptions of the Barriers to Receiving and Delivering Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health Settings. Community Ment Health J. 2019 01; 55(1):83-99. Wolitzky-Taylor K, Chung B, Bearman SK, Arch J, Grossman J, Fenwick K, Lengnick-Hall R, Miranda J. PMID: 29508179; PMCID: PMC6123294.

View in: PubMed Mentions: 9 Fields:
Psy Psychology
Translation:Humans